Press "Enter" to skip to content

FDA grants fast track designation to vofatamab for bladder cancer subset – Healio

admin 0

FDA grants fast track designation to vofatamab for bladder cancer subset  Healio

The FDA granted fast track designation to vofatamab for the treatment of advanced or metastatic urothelial cell carcinoma that harbors fibroblast growth factor …

“bladder cancer” – Google News

(Visited 3 times, 1 visits today)

Leave a Reply

Your email address will not be published. Required fields are marked *